Skip to content
healthcare.dev

Atovaquone Oral Suspension

NDC 81033-105, Atovaquone, suspension, from Kesin Pharma Corporation.

Product NDC
81033-105
Status
Listed
Labeler
Kesin Pharma Corporation
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81033-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
81033-105-228103301052220 CUP, UNIT-DOSE in 1 CARTON (81033-105-22) / 5 mL in 1 CUP, UNIT-DOSE (81033-105-05)
81033-105-428103301054242 CUP, UNIT-DOSE in 1 CARTON (81033-105-42) / 5 mL in 1 CUP, UNIT-DOSE (81033-105-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a2e2c4b-85aa-9b30-e063-6294a90a7bd9
  • NADAC price for package 81033010542

    GET /v1/drugs/nadac/81033010542

Use it

Look up 81033-105 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81033-105 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81033-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.